Zetiq Technologies ^{For Profit}

Zetiq has developed a unique proprietary platform, the CellDetect. It is registered technology, for the ‎detection of cancer cells via discriminate staining of cancer cells among normal ‎cells, while preserving the morphological features of the cells. The unique platform technology enables color discrimination between red cancer ‎cells and green non-cancer cells. Using a simple in-vitro procedure to stain cells ‎they offer dual-color and morphological diagnostic products that are resource-saving and amendable to automation, in a wide range of cancer indications.‎ Products originating from the platform CellDetect:registered: Technology has achieved ‎positive results in targeted clinical trials, and Zetiq intends to expand ‎the development of products of the CellDetect towards the high market ‎value of cancer diagnosis.